BMO Harris Bank Expands Surcharge-Free ATM Service with New Cardtronics ATM Branding Agreement
Feb 07, 2017 12:30 pm UTC| Business
HOUSTON, Feb. 07, 2017 -- BMO Harris Bank is expanding its ATM branding relationship with Cardtronics (Nasdaq:CATM) to provide its customers with surcharge-free ATM access at more than 60 BMO Harris Bank-branded ATMs at...
Feb 07, 2017 12:30 pm UTC| Business
SAN FRANCISCO, Feb. 07, 2017 -- RSA CONFERENCE 2017--EventTracker, a leader in security information and event management (SIEM), today announced that it will be demonstrating SIEMphonic, its comprehensive managed...
CDW Declares Cash Dividend of $0.16 Per Share
Feb 07, 2017 12:05 pm UTC| Business
LINCOLNSHIRE, Ill., Feb. 07, 2017 -- CDW Corporation (NASDAQ:CDW), today announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per common share to be paid on March 10, 2017 to all...
Feb 07, 2017 12:02 pm UTC| Business
Metso Corporation, Stock exchange release, February 7, 2017 at 2:00 p.m. EET Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.'s holding in Metso Metso Corporation has...
GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma
Feb 07, 2017 12:01 pm UTC| Business
- GW intends to advance oncology research and development efforts - LONDON, Feb. 07, 2017 -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on...
GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma
Feb 07, 2017 12:01 pm UTC| Business
- GW intends to advance oncology research and development efforts - LONDON, Feb. 07, 2017 -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on...
ProQR to Present at the LEERINK Partners Global Healthcare Conference
Feb 07, 2017 12:01 pm UTC| Business
LEIDEN, the Netherlands, Feb. 07, 2017 -- ProQR Therapeutics N.V.(Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe orphan diseases such...